We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Parker Laboratories

Manufactures medical ultrasound and electromedical contact media, including gels, solid gels, lotions and pads read more Featured Products: More products

Download Mobile App





Parker Laboratories Introduces Groundbreaking Ultrasound Innovations

By HospiMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Tristel ULT is a high-level disinfectant foam to disinfect cleaned, reusable, non-lumened ultrasound probes (Photo courtesy of Parker Labs)
Image: Tristel ULT is a high-level disinfectant foam to disinfect cleaned, reusable, non-lumened ultrasound probes (Photo courtesy of Parker Labs)

Parker Laboratories Inc. (Fairfield, NJ, USA) is introducing innovative ultrasound products at MEDICA 2023 that are designed to increase patient safety, lower costs, and improve workflow in busy healthcare settings that rely on point-of-care ultrasound. The company is introducing the UltraDrape II UGPIV Barrier and Securement Dressing and Tristel ULT high-level disinfectant foam that promotes patient safety while reducing costs and increasing efficiency for ultrasound-guided percutaneous procedures.

Ultrasound technologies offer important advantages for vascular access procedures such as inserting central lines and peripheral catheters, improving outcomes while also reducing risks and healthcare costs. Hospitals are seeing an increase in the number of patients with difficult vascular access (DiVA) who require ultrasound guidance to achieve peripheral vascular access. UltraDrape II is the next generation of Parker’s groundbreaking UltraDrape, the only dressing designed specifically for use during UGPIV procedures. Like the original, UltraDrape II is a sterile, dual-action barrier and securement dressing that provides a “gel-free” insertion site to decrease the risk of contamination and securement failure both during and after UGPIV procedures.

Tristel ULT is a high-level disinfectant that uses unique, proprietary foam containing chlorine dioxide for reprocessing ultrasound probes. It was recently granted FDA clearance for use as a high-level disinfectant for ultrasound probes used within body cavities and for skin-surface transducers, making it the first product of its kind to be available in the United States. Tristel ULT is the only high-level disinfectant foam that can be safely used on ultrasound probes, and it has been shown to be effective against pathogens ranging from SARS-CoV-2 to Mycobacterium tuberculosis. As a rapid and inexpensive high-level disinfectant, Tristel ULT represents an important advance offering several advantages over other methods of high-level disinfection currently on the market.

“As the use of ultrasound guidance for vascular access procedures increases, so does the need for supplies that make these procedures safer and more efficient, without increasing costs,” said Neal Buchalter, president of Parker Laboratories. “These new products are just a few of the innovative and cost-effective solutions we are committed to bring to market to increase patient safety and improve workflow for busy vascular access clinicians.”

Related Links:
Parker Laboratories Inc.

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Semi-Automatic Mobile Cushion System
CariChair
New
3-Channel ECG
ECG-1003p

Print article

Channels

Critical Care

view channel
Image: The study revealed how stress-related alterations in blood flow and blood vessel function are closely associated with heart disease (Photo courtesy of 123RF)

New Cardiovascular Risk Score Uses Stress Test to Predict Heart Disease More Accurately

A recent study has paved the way for the development of a new cardiovascular reactivity risk score, which could improve the ability to identify high-risk patients under stress and accelerate their diagnosis... Read more

Surgical Techniques

view channel
Image: Application of Pericelle to the porcine model of femoral arterio-venous fistula (Photo courtesy of Bioactive Materials, DOI:10.1016/j.bioactmat.2024.10.005)

Nanotechnology-Based Drug Delivery System Could Help Dialysis and Heart Patients Avoid Repeat Surgeries

Revascularization procedures are essential for treating cardiovascular disease by restoring the necessary blood flow. For instance, a surgeon may transfer a vein from the leg to the heart to help patients... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Medica 2023
Copyright © 2000-2025 Globetech Media. All rights reserved.